Web Masterclass* on Biosimilars in four 1 hour Modules: How to Manage Key Market Challenges and Opportunities

18,19, 20 and 21 June, 15.00 hours, Central European Time (CET)

Module 1, 18 June, 15.00 CET

• Regulatory Affairs and Market Access: focus on market situation to date, early developments in EU, Canada, Australia and Japan, new law and initial regulatory guidelines in US.
• Register here for Module 1

Module 2, 19 June, 15.00 CET

• Prospects for Biosimilars: focus on challenges with patents/exclusivity periods, product development, manufacturing, regulatory demands, competition and stakeholders expectations
• Register here for Module 2
  

Partner and webinar host: 

Who will benefit

• Regulatory affairs and market access managers
• Pricing and reimbursement managers
• Business development managers
• Marketing and sales managers
• Product/brand managers
• Financial/budgeting managers

Registration - CLICK HERE TO SEE DETAILS AND REGISTER ONLINE. Registration fee is 100 EUR per Module and can be paid by credit/debit card or by bank transfer. Registered participants will receive invoice and confirmation by direct e-mail communication.

Module 3, 20 June, 15.00 CET

• Modelling Product Launch Strategy: a case study focus on launch strategy design and optimization by dynamic resource modelling (P&R, marketing and sales budget, patient flow and doctor adoption)

• Register here for Module 3
  

Module 4, 21 June, 15.00 CET

• Launch Strategy What-if Scenario Simulation: focus on generating what-if launch strategy scenarios by working with a software simulation market model in an virtual learning-by-experimentation environment

• Register here for Module 4
  

Course Leaders

Don Macarthur is an independent industry consultant on international pharmaceutical business issues, especially those relating to Europe and parts of Asia. Specialities include pricing & reimbursement, biosimilars/generics, GP & hospital market access, funding of medicines, orphan drugs, distribution and parallel trade. With a 40-year career after qualifying as a pharmacist, Don founded the world’s first periodical in its field, Pharma Pricing Review, and has written over 80 major reports.

Martin Kunc has been an independent consultant with projects in Pharmaceuticals (Zeneca, Sandoz and other), previously consultant at Arthur Andersen. Martin has 15 year experience in strategic modelling for evaluating strategic decisions in pricing and product performance management, marketing strategy, performance measurement systems and supply chain. Martin has also taught in diverse business schools in the UK and Latin America.

Ross Kazakov is a specialist in the pharmaceutical industry, applying modelling and simulation for dynamic resource management and strategy optimisation. He has gained 10 year experience in projects related to pricing and reimbursement strategy, marketing and business development, finance and investor relations, market access and regulatory policy development.

*Participants will have the opportunity to work in a unique interactive learning environment and test their business modelling skills by free access to our specially designed Business Simulator software.